The hypothesis that insulin resistance and impaired insulin‐like growth factor signaling contribute to Alzheimer's disease (AD) has led to the designation of AD as “type 3 diabetes.” Ajuga chamaepitys subsp. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.